Exxonmobil Investment Management Inc. TX decreased its position in PerkinElmer, Inc. (NYSE:PKI) by 12.9% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 17,525 shares of the medical research company’s stock after selling 2,602 shares during the quarter. Exxonmobil Investment Management Inc. TX’s holdings in PerkinElmer were worth $1,281,000 at the end of the most recent quarter.
Other hedge funds have also recently bought and sold shares of the company. Ontario Teachers Pension Plan Board lifted its holdings in PerkinElmer by 36.3% in the second quarter. Ontario Teachers Pension Plan Board now owns 95,415 shares of the medical research company’s stock valued at $6,502,000 after acquiring an additional 25,404 shares during the period. State of Wisconsin Investment Board bought a new position in PerkinElmer in the third quarter valued at about $1,673,000. Bessemer Group Inc. lifted its holdings in PerkinElmer by 22.2% in the third quarter. Bessemer Group Inc. now owns 27,149 shares of the medical research company’s stock valued at $1,873,000 after acquiring an additional 4,936 shares during the period. Sivik Global Healthcare LLC lifted its holdings in PerkinElmer by 12.5% in the third quarter. Sivik Global Healthcare LLC now owns 90,000 shares of the medical research company’s stock valued at $6,207,000 after acquiring an additional 10,000 shares during the period. Finally, King Luther Capital Management Corp increased its position in PerkinElmer by 1.3% in the third quarter. King Luther Capital Management Corp now owns 2,562,833 shares of the medical research company’s stock worth $176,759,000 after buying an additional 32,248 shares in the last quarter. 91.37% of the stock is currently owned by institutional investors.
A number of analysts have commented on PKI shares. Morgan Stanley upped their price target on PerkinElmer from $77.00 to $78.00 and gave the stock an “overweight” rating in a research report on Friday, November 3rd. Evercore ISI started coverage on PerkinElmer in a research report on Wednesday, January 3rd. They issued an “in-line” rating and a $77.00 price target for the company. Robert W. Baird upped their price target on PerkinElmer from $75.00 to $78.00 and gave the stock an “outperform” rating in a research report on Friday, November 3rd. Citigroup restated a “buy” rating and issued a $80.00 price target (up previously from $74.00) on shares of PerkinElmer in a research report on Tuesday, September 26th. Finally, Zacks Investment Research upgraded PerkinElmer from a “hold” rating to a “buy” rating and set a $86.00 price target for the company in a research report on Monday, January 8th. One equities research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and six have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $72.29.
Shares of PerkinElmer, Inc. (NYSE PKI) opened at $79.65 on Thursday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 2.09 and a current ratio of 2.59. PerkinElmer, Inc. has a 1 year low of $50.59 and a 1 year high of $79.79. The stock has a market capitalization of $8,780.00, a PE ratio of 36.04, a P/E/G ratio of 1.90 and a beta of 0.77.
The firm also recently announced a quarterly dividend, which will be paid on Friday, February 9th. Investors of record on Friday, January 19th will be given a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a dividend yield of 0.35%. The ex-dividend date of this dividend is Thursday, January 18th. PerkinElmer’s dividend payout ratio is currently 12.67%.
In related news, Director Alexis P. Michas sold 5,000 shares of the stock in a transaction dated Thursday, November 30th. The stock was sold at an average price of $73.18, for a total transaction of $365,900.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Andrew Okun sold 12,680 shares of the stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $72.00, for a total value of $912,960.00. Following the sale, the insider now owns 25,121 shares of the company’s stock, valued at approximately $1,808,712. The disclosure for this sale can be found here. Insiders have sold 86,336 shares of company stock valued at $6,114,917 in the last quarter. 2.20% of the stock is currently owned by company insiders.
ILLEGAL ACTIVITY NOTICE: “Exxonmobil Investment Management Inc. TX Sells 2,602 Shares of PerkinElmer, Inc. (PKI)” was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this article on another domain, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark law. The correct version of this article can be accessed at https://www.dispatchtribunal.com/2018/01/18/exxonmobil-investment-management-inc-tx-sells-2602-shares-of-perkinelmer-inc-pki.html.
PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets.
Want to see what other hedge funds are holding PKI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PerkinElmer, Inc. (NYSE:PKI).
Receive News & Ratings for PerkinElmer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer and related companies with MarketBeat.com's FREE daily email newsletter.